Which Sources of Flavonoids: Complex Diets or Dietary Supplements?
Open Access
- 1 January 2011
- journal article
- research article
- Published by Elsevier BV in Advances in Nutrition: An International Review Journal
- Vol. 2 (1), 8-14
- https://doi.org/10.3945/an.110.000026
Abstract
There is increasing interest in the potential health benefits of dietary flavonoids. Fruits and vegetables, tea, and cocoa are rich natural sources of flavonoids. Epidemiological studies have indicated that consumption of these foods is likely to be associated with a reduced risk of cardiovascular disease, but the etiology of this benefit is not yet clearly defined. Furthermore, in some acute interventions, a positive effect of tea and cocoa on vascular function has been reported. An alternative source of flavonoids is dietary supplements, which have become increasingly popular in the recent past. In this context, it needs to be critically evaluated whether vascular health-promoting and other positive properties of flavonoid-rich diets can be replaced by purified flavonoids as dietary supplements. Plant sources of flavonoids contain a complex mixture of secondary plant metabolites and not only flavonoids per se. This complex mixture of secondary plant metabolites cannot be simply exchanged by single purified compounds as dietary supplements. If flavonoids are given as dietary supplements, toxicity issues as well as nutrient drug interactions need to be taken into account. Purified flavonoids given in high doses as dietary supplements may affect trace element, folate, and vitamin C status. Furthermore, they may exhibit antithyroid and goitrogenic activities. In this review article, the available literature on the safety issues surrounding high dose supplemental flavonoid consumption has been summarized.Keywords
This publication has 103 references indexed in Scilit:
- Flavanols and Anthocyanins in Cardiovascular Health: A Review of Current EvidenceInternational Journal of Molecular Sciences, 2010
- Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat dietThe Journal of Nutritional Biochemistry, 2009
- Flavonoid–drug interactions: Effects of flavonoids on ABC transportersLife Sciences, 2006
- Genetic Polymorphisms of Drug-Metabolising Enzymes and Drug Transporters in the Chemotherapeutic Treatment of CancerClinical Pharmacokinetics, 2006
- Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen‐stimulated platelet activation pathway in humansJournal of Thrombosis and Haemostasis, 2004
- Inhibition of human cytochromes P450 by components of Ginkgo bilobaJournal of Pharmacy and Pharmacology, 2004
- Differences Between Lovastatin and Simvastatin Hydrolysis in Healthy Male and Female Volunteers: Gut Hydrolysis of Lovastatin is Twice that of SimvastatinThe Scientific World Journal, 2003
- Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 2002
- Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF‐α secretion, and NF‐κB‐dependent gene expression in RAW 264.7 macrophagesFEBS Letters, 2000
- Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoidsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994